View Item 

Show simple item record

Molnupiravir for the Treatment of COVID-19. Information for Patients

dc.date.accessioned2022-07-01T17:12:37Z
dc.date.available2022-07-01T17:12:37Z
dc.date.issued2022-07-01
dc.identifier.govdocPAHO/HSS/MT/COVID-19/22-0022
dc.identifier.urihttps://iris.paho.org/handle/10665.2/56132
dc.description.abstractThe Pan American Health Organization presents this information sheet with recommendations on the use of molnupiravir addressed to patients. Molnupiravir is a prodrug that significantly inhibits SARS-CoV-2 replication. It is used for the treatment of mild and moderate COVID-19 in patients who are at high risk of complications, and has shown a significant reduction in the rate of hospitalization or death of patients with COVID-19.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectProdrugsen_US
dc.subjectPregnancyen_US
dc.subjectMolnupiraviren_US
dc.subjectAccess to Treatmenten_US
dc.titleMolnupiravir for the Treatment of COVID-19. Information for Patientsen_US
dc.typeInformation kit (folder, banner, brochure)en_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/56087en_US
paho.contributor.departmentHealth Systems and Services (HSS)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail
Name:
PAHOHSSMTCOVID19220022_eng.pdf
Size:
974.3Kb
Format:
PDF
Description:
English; 2 pages
View/Open

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO